Tuberculosis vaccine H56IC (Valneva/Statens Serum Institut)
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameTuberculosis vaccine H56IC (Valneva/Statens Serum Institut)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStatens Serum Institut
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A